Sharon Camden, MD
Dermatology · Glen Allen, VANPI 1386729747
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $806 and has fallen 75.1% since, to $200 in 2025.
Across 128 payments — averaging $22.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$519
- Amgen$298
- UCB, Inc.$274
- Sanofi$209
- Sun Pharmaceutical Industries Inc.$171
- Johnson & Johnson$166
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,839100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $519 |
| Amgen | 10 | $298 |
| UCB, Inc. | 11 | $274 |
| Sanofi | 7 | $209 |
| Sun Pharmaceutical Industries Inc. | 6 | $171 |
| Johnson & Johnson | 8 | $166 |
| Pfizer | 9 | $154 |
| Regeneron Healthcare Solutions, Inc. | 6 | $148 |
| Incyte Corporation | 5 | $127 |
| Arcutis Biotherapeutics, Inc. | 6 | $121 |
| Novartis | 6 | $121 |
| Dermavant Sciences, Inc. | 5 | $107 |
| E.r. Squibb & Sons, L.L.C. | 6 | $95 |
| VYNE Pharmaceuticals Inc. | 2 | $65 |
| Lilly USA, LLC | 3 | $62 |
| LEO Pharma Inc. | 3 | $57 |
| Galderma Laboratories, L.p. | 3 | $47 |
| Biofrontera Inc. | 2 | $34 |
| Merck | 2 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
How this compares
$2,839 in reported general payments places this provider in the 55th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 60 | $4,120 |
| Ketoconazole | 141 | $3,628 |
| Metronidazole | 54 | $3,302 |
| Clobetasol Propionate | 74 | $2,403 |
| Betamethasone Dipropionate | 61 | $2,364 |
| Fluocinonide | 48 | $2,199 |
| Tacrolimus | 15 | $1,455 |
| Triamcinolone Acetonide | 147 | $1,104 |
| Cephalexin | 26 | $525 |
| Mupirocin | 75 | $475 |
| Hydrocortisone | 64 | $356 |
| Doxycycline Hyclate | 21 | $283 |
| ValacyclovirValacyclovir Hcl | 27 | $175 |
| Acyclovir | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Glen Allen
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
- David PariserNorfolk$261K
- Hema SundaramFairfax$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.